130 related articles for article (PubMed ID: 37746945)
1. Integrated analysis of SKA1-related ceRNA network and SKA1 immunoassays in HCC: A study based on bioinformatic.
Zeng F; Xu Z; Zhuang P
Medicine (Baltimore); 2023 Sep; 102(38):e34826. PubMed ID: 37746945
[TBL] [Abstract][Full Text] [Related]
2. Analysis on EZH2: mechanism identification of related CeRNA and its immunoassay in hepatocellular carcinoma.
Zhao H; Liu H; Kang W; Zhan C; Man Y; Qu T
BMC Med Genomics; 2023 Aug; 16(1):201. PubMed ID: 37626362
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced lncRNA MRVI1-AS1 accelerates hepatocellular carcinoma progression by recruiting RNA-binding protein CELF2 to stabilize SKA1 mRNA.
Tuo H; Liu R; Wang Y; Yang W; Liu Q
World J Surg Oncol; 2023 Mar; 21(1):111. PubMed ID: 36973749
[TBL] [Abstract][Full Text] [Related]
4. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
[TBL] [Abstract][Full Text] [Related]
7. SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.
Chen Y; Zhao J; Jiao Z; Wang W; Wang D; Yu X; Shi Z; Ge N; Pan Q; Xia J; Niu W; Zhao R; Zhang X; Du W
BMC Cancer; 2018 Dec; 18(1):1240. PubMed ID: 30537941
[TBL] [Abstract][Full Text] [Related]
8. Candidate lncRNA-miRNA-mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis.
Zhang R; Jiang YY; Xiao K; Huang XQ; Wang J; Chen SY
J Cancer Res Clin Oncol; 2020 Jan; 146(1):87-96. PubMed ID: 31758243
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
10. Identification of Hypoxia-Related Prognostic Signature and Competing Endogenous RNA Regulatory Axes in Hepatocellular Carcinoma.
Tang Y; Zhang H; Chen L; Zhang T; Xu N; Huang Z
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362375
[TBL] [Abstract][Full Text] [Related]
11. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
12. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q
Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K
Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493
[TBL] [Abstract][Full Text] [Related]
14. miRNA-10a-5p inhibits cell metastasis in hepatocellular carcinoma via targeting SKA1.
Shen D; Zhao HY; Gu AD; Wu YW; Weng YH; Li SJ; Song JY; Gu XF; Qiu J; Zhao W
Kaohsiung J Med Sci; 2021 Sep; 37(9):784-794. PubMed ID: 34002462
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma.
Li G; Wang Z; Chen D; Yin J; Mo Z; Sun B; Yang T; Zhang X; Zhai Z; Li Y; Chen P; Dai Y; Wang Z; Ma J
Front Cell Infect Microbiol; 2022; 12():1025900. PubMed ID: 36204642
[TBL] [Abstract][Full Text] [Related]
16. Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.
Cao D; Wang Y; Li D; Wang L
Crit Rev Eukaryot Gene Expr; 2019; 29(6):539-549. PubMed ID: 32422009
[TBL] [Abstract][Full Text] [Related]
17. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
18. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
19. The SNHG1-Centered ceRNA Network Regulates Cell Cycle and Is a Potential Prognostic Biomarker for Hepatocellular Carcinoma.
Zhou L; Zhang Q; Deng H; Ou S; Liang T; Zhou J
Tohoku J Exp Med; 2022 Nov; 258(4):265-276. PubMed ID: 36244757
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway.
Zeng Y; Xu Q; Xu N
Bioengineered; 2021 Dec; 12(1):7964-7974. PubMed ID: 34565286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
